1. Home
  2. XBIO vs LICN Comparison

XBIO vs LICN Comparison

Compare XBIO & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • LICN
  • Stock Information
  • Founded
  • XBIO N/A
  • LICN 2004
  • Country
  • XBIO United States
  • LICN China
  • Employees
  • XBIO N/A
  • LICN N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • XBIO Health Care
  • LICN
  • Exchange
  • XBIO Nasdaq
  • LICN Nasdaq
  • Market Cap
  • XBIO 4.2M
  • LICN 3.6M
  • IPO Year
  • XBIO N/A
  • LICN 2023
  • Fundamental
  • Price
  • XBIO $3.53
  • LICN $4.25
  • Analyst Decision
  • XBIO Hold
  • LICN
  • Analyst Count
  • XBIO 1
  • LICN 0
  • Target Price
  • XBIO N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • XBIO 169.6K
  • LICN 75.2K
  • Earning Date
  • XBIO 08-12-2025
  • LICN 01-01-0001
  • Dividend Yield
  • XBIO N/A
  • LICN N/A
  • EPS Growth
  • XBIO N/A
  • LICN N/A
  • EPS
  • XBIO N/A
  • LICN N/A
  • Revenue
  • XBIO $2,582,728.00
  • LICN $41,477,000.00
  • Revenue This Year
  • XBIO $14.23
  • LICN N/A
  • Revenue Next Year
  • XBIO $7.14
  • LICN N/A
  • P/E Ratio
  • XBIO N/A
  • LICN N/A
  • Revenue Growth
  • XBIO 5.63
  • LICN 4.32
  • 52 Week Low
  • XBIO $2.20
  • LICN $2.60
  • 52 Week High
  • XBIO $5.27
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 58.63
  • LICN 47.63
  • Support Level
  • XBIO $2.65
  • LICN $3.80
  • Resistance Level
  • XBIO $5.27
  • LICN $4.26
  • Average True Range (ATR)
  • XBIO 0.45
  • LICN 0.33
  • MACD
  • XBIO 0.09
  • LICN -0.03
  • Stochastic Oscillator
  • XBIO 33.61
  • LICN 37.85

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: